Market Overview:
The global dermatology drugs for pets market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of skin diseases in pets, rising awareness about pet health, and growing demand for advanced veterinary care. By type, the antibiotics segment is expected to account for the largest share of the global dermatology drugs for pets market in 2018. This segment is projected to grow at a CAGR of 6% during the forecast period. By application, pet clinics are expected to account for the largest share of the global dermatology drugs for pets market in 2018.
Product Definition:
Dermatology drugs for pets are used to treat a variety of skin conditions in animals. They can help to clear up skin infections, reduce inflammation, and relieve itching. Dermatology drugs for pets are important because they can help keep animals healthy and comfortable.
Antibiotics:
Antibiotics are drugs used to treat bacterial infections. Bacterial infection includes skin infections, urinary tract infections, pneumonia (lung infection), and earaches. Antibiotics work by killing the bacteria or inhibiting their growth.
Antifungal Drugs:
Antifungal drugs are used in dermatology for the treatment of skin infections. The most common types of infections that require antifungal medication include ringworm, athlete's foot, jock itch, and fungal infection. Fungal infection is caused by fungi that are present on the skin without causing any harm. However some fungi such as molds or yeast can cause diseases if they remain on the skin too long or if one is allergic to them.
Application Insights:
On the basis of application, the global dermatology drugs for pets market is segmented into pets clinics, pet hospitals and others. The others segment includes animal boarding kennels and grooming parlors. Pet hospitals held the largest share in 2017 due to increasing number of hospitalizations for skin diseases in dogs and cats. Moreover, rising demand for preventive measures against fleas, ticks & worms will boost product usage over the forecast period.
Pets clinics are anticipated to be fastest growing application owing to their ability to treat acute as well as chronic skin conditions at a lower cost when compared with pet hospitals or veterinary surgeries. Moreover, they offer more convenience due to round-the-clock availability resulting in reduced travel time required by owners for treatment purposes which further reduces treatment costs considerably.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to rising pet ownership, increasing awareness about animal health and well-being, availability of effective treatment options for pets at affordable prices, and high healthcare spending by pet owners. In addition, favorable reimbursement policies for veterinary medicinal products are also expected to drive the regional market during the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising disposable income coupled with growing population of urban cities such as Delhi NCR (National Capital Region) and Mumbai city in India.
Growth Factors:
- Increasing demand for dermatology drugs for pets owing to rising incidences of skin diseases in animals.
- Growing awareness about the benefits of using dermatology drugs for pets among pet owners.
- Rising number of veterinary clinics and hospitals offering specialized services in dermatology drugs for pets treatment.
- Technological advancements in the field of veterinary medicine that has led to introduction of novel and improved products in the market catering to specific needs of animals with skin diseases .
Scope Of The Report
Report Attributes
Report Details
Report Title
Dermatology Drugs for Pets Market Research Report
By Type
Antibiotics, Antifungal Drugs, Others
By Application
Pets Clinics, Pets Hospitals, Others
By Companies
Bayer Animal Health, Boehringer Ingelheim Vetmedica, Ceva Sante Animale, Zoetis Inc., Elanco, IDEXX Laboratories, Merial, Vetoquinol S.A.panies, Virbac S.A.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
212
Number of Tables & Figures
149
Customization Available
Yes, the report can be customized as per your need.
Global Dermatology Drugs for Pets Market Report Segments:
The global Dermatology Drugs for Pets market is segmented on the basis of:
Types
Antibiotics, Antifungal Drugs, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pets Clinics, Pets Hospitals, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer Animal Health
- Boehringer Ingelheim Vetmedica
- Ceva Sante Animale
- Zoetis Inc.
- Elanco
- IDEXX Laboratories
- Merial
- Vetoquinol S.A.panies
- Virbac S.A.
Highlights of The Dermatology Drugs for Pets Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics
- Antifungal Drugs
- Others
- By Application:
- Pets Clinics
- Pets Hospitals
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dermatology Drugs for Pets Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Dermatology drugs for pets are medications used to treat skin conditions in animals. These medications can be used to treat a wide variety of problems, including infections, allergies, and dermatitis.
Some of the major players in the dermatology drugs for pets market are Bayer Animal Health, Boehringer Ingelheim Vetmedica, Ceva Sante Animale, Zoetis Inc., Elanco, IDEXX Laboratories, Merial, Vetoquinol S.A.panies, Virbac S.A..
The dermatology drugs for pets market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dermatology Drugs for Pets Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Dermatology Drugs for Pets Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Dermatology Drugs for Pets Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Dermatology Drugs for Pets Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Dermatology Drugs for Pets Market Size & Forecast, 2020-2028
4.5.1 Dermatology Drugs for Pets Market Size and Y-o-Y Growth
4.5.2 Dermatology Drugs for Pets Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antibiotics
5.2.2 Antifungal Drugs
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pets Clinics
6.2.2 Pets Hospitals
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Dermatology Drugs for Pets Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Dermatology Drugs for Pets Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antibiotics
9.6.2 Antifungal Drugs
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pets Clinics
9.10.2 Pets Hospitals
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antibiotics
10.6.2 Antifungal Drugs
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pets Clinics
10.10.2 Pets Hospitals
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antibiotics
11.6.2 Antifungal Drugs
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pets Clinics
11.10.2 Pets Hospitals
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antibiotics
12.6.2 Antifungal Drugs
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pets Clinics
12.10.2 Pets Hospitals
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antibiotics
13.6.2 Antifungal Drugs
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pets Clinics
13.10.2 Pets Hospitals
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Dermatology Drugs for Pets Market: Competitive Dashboard
14.2 Global Dermatology Drugs for Pets Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer Animal Health
14.3.2 Boehringer Ingelheim Vetmedica
14.3.3 Ceva Sante Animale
14.3.4 Zoetis Inc.
14.3.5 Elanco
14.3.6 IDEXX Laboratories
14.3.7 Merial
14.3.8 Vetoquinol S.A.panies
14.3.9 Virbac S.A.
